Literature DB >> 11808959

Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy.

Takeshi Kurihara, Atsushi Maeda, Mutsuo Shigemoto, Katsuko Yamashita, Etsuko Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11808959     DOI： 10.1111/j.1572-0241.2002.05413.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  13 in total

1.  A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors:  Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

2.  Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.

Authors:  Cynthia Levy; Keith D. Lindor
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

3.  Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.

Authors:  Runalia Bahar; Kimberly A Wong; Chung H Liu; Christopher L Bowlus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 4.  Fibrates and cholestasis.

Authors:  Nisanne S Ghonem; David N Assis; James L Boyer
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

5.  Fenofibrate in primary biliary cirrhosis: a pilot study.

Authors:  E N Liberopoulos; M Florentin; M S Elisaf; D P Mikhailidis; E Tsianos
Journal:  Open Cardiovasc Med J       Date:  2010-04-28

Review 6.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

7.  Treatment of autoimmune liver disease: current and future therapeutic options.

Authors:  Palak J Trivedi; Gideon M Hirschfield
Journal:  Ther Adv Chronic Dis       Date:  2013-05       Impact factor: 5.091

Review 8.  Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.

Authors:  Francesca Saffioti; Kurinchi Selvan Gurusamy; Leonardo Henry Eusebi; Emmanuel Tsochatzis; Brian R Davidson; Douglas Thorburn
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28

Review 9.  Nuclear receptors as drug targets in cholestatic liver diseases.

Authors:  Emina Halilbasic; Anna Baghdasaryan; Michael Trauner
Journal:  Clin Liver Dis       Date:  2013-05       Impact factor: 6.126

Review 10.  Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis.

Authors:  Qin Yin; Jingjing Li; Yujing Xia; Rong Zhang; Jianrong Wang; Wenxia Lu; Yuqing Zhou; Yuanyuan Zheng; Huerxidan Abudumijiti; Rongxia Chen; Kan Chen; Sainan Li; Tong Liu; Fan Wang; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Drug Des Devel Ther       Date:  2015-09-30       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.